Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,099 | -21,104 | -12,700 | -16,929 | -4,986 |
| Depreciation Amortization | 1,018 | 959 | 1,102 | 1,247 | 1,049 |
| Accounts receivable | -30,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,674 | 1,330 | 384 | -362 | -187 |
| Other Working Capital | 1,708 | 1,463 | 283 | -1,176 | -6,789 |
| Other Operating Activity | 22,353 | -798 | -265 | 856 | 754 |
| Operating Cash Flow | $-23,346 | $-18,151 | $-11,196 | $-16,364 | $-10,159 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,966 | -2,481 | 8,503 | 10,800 | 23,052 |
| PPE Investments | -497 | -276 | -52 | -408 | -2,604 |
| Purchase Sale Intangibles | -51 | -80 | -82 | -129 | -65 |
| Other Investing Activity | -51 | -81 | -82 | -129 | -65 |
| Investing Cash Flow | $-11,514 | $-2,837 | $8,369 | $10,263 | $20,382 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -10 |
| Common Stock Issued | 55,179 | 21,479 | 900 | 123 | 196 |
| Financing Cash Flow | $55,179 | $21,479 | $900 | $123 | $186 |
| Beginning Cash Position | 8,839 | 8,348 | 10,276 | 16,254 | 8,456 |
| End Cash Position | 29,157 | 8,839 | 8,348 | 10,276 | 18,865 |
| Net Cash Flow | $20,318 | $491 | $-1,928 | $-5,978 | $10,410 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,346 | -18,151 | -11,196 | -16,364 | -10,159 |
| Capital Expenditure | -497 | -276 | -52 | -408 | -2,604 |
| Free Cash Flow | -23,844 | -18,427 | -11,248 | -16,772 | -12,763 |